Cipla faces headwinds but remains resilient with strong product portfolio, robust earnings growth potential, and reasonable ...

This combination drug, that was previously available only in the U.S. and European countries, was first launched in India by Cipla on Thursday. In the U.S. and Europe this combination drug costs Rs.

NEW DELHI: Indian Pharmaceutical company Cipla has offered to manufacture an ... The patent for Tamiflu is pending in India and the government is yet to decide on how to make the drug in the ...

The Useful Plants of India, with Notices of their chief Value in Commerce, Medicine, and the Arts. By Col. Heber Drury. Third edition, with Additions and Corrections. (W. H. Allen and Co., ...

New Delhi, Feb 8 () Homegrown pharma firm Cipla on Saturday announced the acquisition ... by Wanbury have a market size of Rs 3,100 crore in India with sales value of Rs 59.6 crore.

A U.S.-headquartered manufacturer of green hydrogen fuel cells wants to build what the company’s president called “multi-gigawatt” electrolyzer projects in India. Sanjay Shrestha ...

Cybersecurity firm CYFIRMA Research reports that notable organisations like Jio, Airtel, Cipla and others are on the radar of Chinese hackers to “teach India a lesson”. Other comments ...

Blackberry plants in India exhibit sprawling growth, with fruits transitioning from green to red during ripening and finally turning deep black when fully mature. The two primary varieties ...

However, some 70% of tyres imported by India from the UK and the rest of the world end up in makeshift industrial plants, where they are subjected to what amounts to an extreme form of cooking ...

In the note that Nomura shared based on the key takeaways from the conversation, Vohra highlighted that he is “positive on the GLP-1 and semaglutide opportunity in India as Cipla prepares to ...

India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd., Glenmark Pharmaceuticals ... Expenditure on equipment, plants, R&D, clinical trials, product development ...

The company's current investment cycle of ₹3,200 crore is in its final phase of implementation with its latest announcement of three new plants in India. "So the commitment we had made was for ...